Scholarlink

Purpose <p>Radiofrequency ablation (RFA) is a minimally invasive treatment for selected patients with early-stage breast cancer, but ablation time varies substantially. We investigated clinical, imaging, procedural, and pathological factors associated with prolonged ablation time.</p> Methods <p>We retrospectively analyzed 72 patients who underwent breast RFA at a single institution between April 2024 and November 2025. Clinical variables, ultrasonographic tumor characteristics, mammography-based background breast density, ultrasonography-based puncture-site breast density, initial impedance, maximum power, and temperature were evaluated. Exploratory pathological assessment of stromal predominance was performed in 48 patients.</p> Results <p>The median ablation time was 649.5&#xa0;s (IQR 508.8-879.5). Ablation target size, ultrasonographic tumor dimensions, background density, puncture-site density (<i>p</i> &lt; 0.001), and maximum power were positively associated with ablation time, whereas initial impedance showed a negative correlation. Puncture-site density and initial impedance were strongly inversely correlated (<i>r</i> = -0.716, <i>p</i> &lt; 0.001). Mammography-based background density and ultrasonography-based puncture-site density showed substantial agreement (60/72, 83.3%) and strong ordinal correlation (Spearman <i>r</i> = 0.838, <i>p</i> &lt; 0.001). In multivariable analysis, ablation target size (β = 60.26&#xa0;s/mm, <i>p</i> = 0.003), initial impedance conditional on puncture-site density (β = 2.89&#xa0;s/Ω, <i>p</i> = 0.015), and puncture-site density (β = 388.33&#xa0;s/category, <i>p</i> &lt; 0.001) were independently associated with prolonged ablation time.</p> Conclusion <p>Ablation time is influenced by tumor size, local tissue density, impedance, and possibly stromal predominance. Local ultrasonographic assessment complements mammographic density for procedure-specific RFA planning, although prospective validation is required.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Clinical and imaging factors associated with prolonged ablation time in radiofrequency ablation for early-stage breast cancer

  • 期刊论文

  • 发表日期：

    2026年7月28日

查看全文
  • Chika Watanabe,
  • Shinichiro Kashiwagi,
  • Mariko Nishikawa,
  • Asuka Kochi,
  • Koji Takada,
  • Yukie Tauchi,
  • Kana Ogisawa,
  • Haruhito Kinoshita,
  • Masatsune Shibutani,
  • Tamami Morisaki

摘要

Purpose

Radiofrequency ablation (RFA) is a minimally invasive treatment for selected patients with early-stage breast cancer, but ablation time varies substantially. We investigated clinical, imaging, procedural, and pathological factors associated with prolonged ablation time.

Methods

We retrospectively analyzed 72 patients who underwent breast RFA at a single institution between April 2024 and November 2025. Clinical variables, ultrasonographic tumor characteristics, mammography-based background breast density, ultrasonography-based puncture-site breast density, initial impedance, maximum power, and temperature were evaluated. Exploratory pathological assessment of stromal predominance was performed in 48 patients.

Results

The median ablation time was 649.5 s (IQR 508.8-879.5). Ablation target size, ultrasonographic tumor dimensions, background density, puncture-site density (p < 0.001), and maximum power were positively associated with ablation time, whereas initial impedance showed a negative correlation. Puncture-site density and initial impedance were strongly inversely correlated (r = -0.716, p < 0.001). Mammography-based background density and ultrasonography-based puncture-site density showed substantial agreement (60/72, 83.3%) and strong ordinal correlation (Spearman r = 0.838, p < 0.001). In multivariable analysis, ablation target size (β = 60.26 s/mm, p = 0.003), initial impedance conditional on puncture-site density (β = 2.89 s/Ω, p = 0.015), and puncture-site density (β = 388.33 s/category, p < 0.001) were independently associated with prolonged ablation time.

Conclusion

Ablation time is influenced by tumor size, local tissue density, impedance, and possibly stromal predominance. Local ultrasonographic assessment complements mammographic density for procedure-specific RFA planning, although prospective validation is required.